CoChat

Elevated PCSK9 Levels in Untreated Patients With Heterozygous or Homozygous Familial Hypercholesterolemia and the Response to High‐Dose Statin Therapy

Open access
Raal, Frederick, Panz, Vanessa, Immelman, Andrew, Pilcher, Gillian · 2013 · Journal of the American Heart Association
Cited by 132

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Background: Proprotein convertase subtilisin kexin type 9 ( PCSK 9) is an enzyme that impairs low‐density lipoprotein cholesterol ( LDL ‐C) clearance from the plasma by promoting LDL receptor degradation. Patients with familial hypercholesterolemia ( FH ) have reduced or absent LDL receptors and should therefore have elevated PCSK 9 levels. Methods and Results: Fasting lipograms and PCSK 9 levels were measured 51 homozygous FH ( HoFH ), 20 heterozygous FH ( HeFH ), and 20 normocholesterolemic control subjects. Levels were repeated following high‐dose statin therapy. LDL ‐C levels were significantly higher in untreated HoFH (13.4±0.7 mmol/L) and HeFH patients (7.0±0.2 mmol/L) compared with controls (2.6±0.1 mmol/L) ( P <0.01). Statin therapy decreased LDL ‐C levels from 13.4±0.7 to 11.1±0.7 mmol/L in HoFH and from 7.0±0.2 to 3.6±0.2 mmol/L in HeFH patients ( P <0.01). PCSK 9 levels were higher in untreated HoFH (279±27 ng/mL) and HeFH (202±14 ng/mL) than in controls (132±10 ng/mL) (both P <0.01). High‐dose statin therapy increased PCSK 9 levels from 279±27 to 338±50 ng/mL in HoFH , and significantly so in the HeFH patients from 202±14 to 278±20 ng/mL ( P <0.01). Linear regression analysis showed a correlation between PCSK 9 and LDL ‐C (r=0.6769; P <0.0001); however, this was eliminated following statin therapy (r=0.2972; P =0.0625). Conclusions: PCSK 9 levels are elevated in untreated FH patients, particularly in those with HoFH . High‐dose statin therapy further increases PCSK 9 levels. PCSK 9 inhibitors might be a beneficial therapy for FH patients, even in those with HoFH .

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/jaha.112.000028

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 132

Metadata

Authors
Raal, F., Panz, V., Immelman, A., & Pilcher, G.
Venue
Journal of the American Heart Association
Published
2013-03-12
Volume
2
Issue
2
Pages
e000028-e000028
ISSN
2047-9980 (ISSN-L)
OpenAlex
W2157115489
Cited by
132
References
7
FWCI
17.66
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.